In this section of the BIO Europe Tradeshow Site, you'll find news releases from our exhibitors. The releases are listed in chronological order and are archived by month and year.
Treatment with TyrNovo's NT219 in combination with targeted cancer drugs, as well as chemotherapy and immuno-oncology therapies, prevented acquired resistance and reversed resistance of colon, lung and head-and-neck cancers in patient-derived xenograft models
